Skip Navigation

Find a Doctor

Find a Researcher

Researchers

James Stuart Ferriss, M.D.

Photo of Dr. James Stuart Ferriss, M.D.
  • Director, F.J. Montz Gynecologic Oncology Fellowship Program
  • Assistant Professor of Gynecology and Obstetrics
Male

Expertise

Cervical Cancer, Endometrial Cancer, Gynecologic Cancers, Gynecologic Oncology, High Risk Endometrial (Uterine) Cancer, Minimally Invasive Surgery, Ovarian Cancer, Robotic Surgery, Uterine Cancer, Vulvar Cancer ...read more

Request an Appointment

Insurance Information

Maryland

410-955-8240
Request Appointment

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

Johns Hopkins Outpatient Center

Appointment Phone: 410-955-8240
601 N. Caroline St.
Baltimore, MD 21287 map
Phone: 410-955-8240

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-955-8240
10755 Falls Road
Pavilion I
Lutherville, MD 21093 map
Phone: 410-955-8240

Background

James Stuart Ferriss is an assistant professor in the Johns Hopkins Department of Gynecology and Obstetrics and director of the F.J. Montz Gynecologic Oncology Fellowship Program.

He is an expert in the care of women with cancers of the uterus, cervix, vulva, vagina, fallopian tubes and ovaries. Dr. Ferriss is passionate about minimally invasive approaches to surgery and has extensive experience with robotic surgery. 

Dr. Ferriss received his undergraduate and medical degrees from Louisiana State University. He then completed his residency in obstetrics and gynecology at the University of Texas Southwestern Medical Center and his fellowship in gynecologic oncology at the University of Virginia.

Prior to joining Johns Hopkins, Dr. Ferriss was associate professor in the departments of women’s health and oncology at the University of Texas at Austin Dell Medical School. Before that, he was assistant professor in the department of obstetrics, gynecology and reproductive sciences at Temple University in Philadelphia.

Dr. Ferriss’ research currently focuses on increasing the diversity of patients recruited to clinical trials by understanding the factors and circumstances that prevent some patients from participating. He is also focused on innovations in surgical and clinical education.

Dr. Ferriss serves on a variety of boards and is a member of NRG Oncology, Mid-Atlantic Gynecologic Oncology Society, American Society of Clinical Oncology, the American College of Surgeons and the American Congress of Obstetricians and Gynecologists.

He has been recognized with several awards and honors, including being named a top doctor in both Austin and Philadelphia for outstanding patient care. Dr. Ferriss’ passion for getting to know each of his patients’ values and personal treatment goals and empowering them to be active participants in their treatment defines his approach to patient care. Dr. Ferriss has special interest in supporting his patients through the entire arc of their cancer care from diagnosis to surgery, chemotherapy, and survivorship and palliative care. 

...read more

Titles

  • Director, F.J. Montz Gynecologic Oncology Fellowship Program
  • Assistant Professor of Gynecology and Obstetrics

Departments / Divisions

Education

Degrees

  • MD, Louisiana State University School of Medicine (2003)

Residencies

  • University of Texas Southwestern Medical Center / Obstetrics and Gynecology (2007)

Fellowships

  • University of Virginia School of Medicine / Gynecologic Oncology (2010)

Board Certifications

  • American Board of Obstetrics and Gynecology / Gynecologic Oncology (2013)
  • American Board of Obstetrics and Gynecology / OB/GYN-General (2011)

Research & Publications

Research Summary

Dr. Ferriss’ research currently focuses on increasing the diversity of patients recruited to clinical trials by understanding the factors and circumstances that prevent some patients from participating. He is also focused on innovations in surgical and clinical education.

Selected Publications

View all on Pubmed

Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov-Dec;16(6):11441151. PMID: 28958736

Jordan SE, Stone D, Yu D, Ferriss JS, Hernandez E, Rubin S. Blood Loss from Robotic Assisted Hysterectomy. J Gynecol Surg 2017 33(2):47-50.

Igwe E, Woodburn J, Davolos J, Shollenberger C, Miller S, Hernandez E, Ferriss JS. Patient Perceptions and Willingness to Participate in Clinical Trials. Gynecol Oncol. 2016 Sep;142(3):520-4. PMID: 27372403.

Guitarte C, Grant J, Zhao H, Wang S, Ferriss JS, Hernandez E. Incisional hernia formation and associated risk factors on a gynecologic oncology service: an exploratory analysis. Arch Gynecol Obstet. 2016;1–7. PMID: 27101367.

Ferriss JS, Java J, Bookman MA, Fleming GF, Monk BJ, Walker JL, Homesley HD, Fowler J, Greer BE, Boente M, Burger RA. Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study. Gynecol Oncol. 2015 Oct;139(1):17-22. PMID: 26216729.

Contact for Research Inquiries

Kelly Gynecologic Oncology Service
600 N. Wolfe St
Phipps 281
Baltimore, MD 21287 map

Activities & Honors

Honors

  • Top Doctor, Austin Monthly Magazine, 2017 - 2019
  • Excellence in Medical Student Teaching, Department of Women’s Health, UT Austin, 2017
  • Academic Scholars & Leaders, Association of Professors in Gynecology & Obstetrics, 2017 - 2018
  • Fellow American College of Surgeons, 2014
  • Young Investigator Award, Gynecologic Oncology Group, 2013 - 2015

Memberships

  • NRG Oncology
  • Mid-Atlantic Gynecologic Oncology Society (MAGOS)
  • American Society of Clinical Oncology (ASCO)
  • American College of Obstetricians and Gynecologists (ACOG)
  • The American College of Surgeons (ACS)

Videos & Media

Lectures and Presentations

  • The CARE study: Communicating about research with empathy
    Panel Presentation, National Communication Association Convention, Salt Lake City, UT (11/08/2018)
  • Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: An NRG oncology/Gynecologic Oncology Group (GOG) study.
    Invited Presentation., American Society of Clinical Oncology Annual Meeting, Chicago, IL (06/04/2018)
  • A Pilot Predictive Model for the Ob/Gyn Residency Match
    Invited Presentation., Academic Scholars and Leaders session of the Association of Professors in Gynecology and Obstetrics, National Harbor, MD (03/03/2018)
  • Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers.
    Oral Presentation., Tampa, FL (03/23/2014)
    Society of Gynecologic Oncology

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button